U.S. Mortgage Finance Stock News

Over the last 7 days, the United States market has experienced a 1.9% drop, yet it remains up by 15% over the past year with earnings projected to grow annually by the same percentage. In this dynamic environment, identifying stocks that are not only resilient but also positioned for growth can be crucial for investors seeking opportunities beyond well-trodden paths.

Wondering if Atlanta Braves Holdings at around US$41.53 is offering good value or just a fan premium? This breakdown is designed to help you see what the current price really represents. The stock has seen a 1% decline over the last 7 days and a 5% decline over the last 30 days, while still showing returns of 4.2% year to date, 3.8% over 1 year, 23.2% over 3 years and 43.2% over 5 years. Recent coverage has focused on the company as a way to gain exposure to a well known sports franchise...

Wondering if Clearwater Analytics Holdings at around US$23.49 is offering good value right now, or if the price already reflects most of the upside you care about. The stock has been relatively steady in the near term, with a 0.9% return over the last 7 days and 0.4% over the last 30 days, while year to date it shows a 2.6% decline and the 1 year return sits at a 12.4% decline, compared with a 48.6% gain over 3 years. Recent coverage has focused on Clearwater Analytics Holdings as a listed...

Hawaiian Electric Industries (NYSE:HE) has agreed to a $100 million settlement to resolve significant stockholder derivative lawsuits. The payment will be funded by insurers and also partially settles a related securities class action. The agreement is subject to final court approval, with upcoming hearings expected to clarify the remaining legal process. For shareholders watching NYSE:HE at a current share price of $14.67, this settlement addresses a key source of legal uncertainty. The...

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Morningstar...

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with anticipated earnings growth of 15% annually in the coming years. In this dynamic environment, identifying promising small-cap stocks with insider buying can offer unique opportunities for investors seeking potential value amidst fluctuating market conditions.

The Morning Bull - US Market Morning Update Monday, Mar, 30 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.5%, as investors weigh rising government bond yields against mixed signals on consumer confidence. The US 10 year yield sits near 4.4%, which means borrowing costs for mortgages, credit cards and companies remain relatively expensive. At the same time, the University of Michigan consumer sentiment index is revised down to 53.3, while...

Despite announcing strong earnings, GDS Holdings Limited's ( NASDAQ:GDS ) stock was sluggish. We think that the market...

OceanPal Inc. ( NASDAQ:SVRN ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

How RBC Bearings' Valuation Stacks Up Against Its Market Price With RBC Bearings' share price around US$532.25, many investors are asking the same question: is the stock pricing in too much optimism, or are markets still underestimating its potential? Recent returns are mixed, with a 0.9% decline over the last 7 days and a 7.6% decline over the last 30 days, set against a 16.0% gain year to date and a 65.4% return over the past year. These moves sit in the context of RBC Bearings' longer term...

For investors considering whether Artivion at around US$35 per share still offers value or whether the recent run has already priced in the story, this article breaks down what the current market price might be implying. The stock has pulled back over the last week and month, with declines of 1.2% and 8.3%, respectively, while still sitting on a 43.6% return over 1 year and 176.1% over 3 years. Recent coverage has focused on Artivion's position in the medical equipment space and investor...

If you are wondering whether Bright Horizons Family Solutions at US$77.99 is priced attractively or asking too much for its prospects, the valuation picture is not as straightforward as the share price alone might suggest. The stock has seen a 4.7% gain over the past 30 days, but that sits against a 21.5% decline year to date and a 38.6% decline over the past year, which can shift how the market views both risk and potential reward. Recent coverage has focused on the company within the...

TPG (TPG) shares were in focus after reports that OpenAI is in advanced talks with the firm and other private equity groups to create a joint venture to distribute OpenAI’s enterprise products. See our latest analysis for TPG. The OpenAI talks arrive during a weak patch for TPG’s share price, which has a 1 month share price return of 9.95% and a year to date share price return of 40.53%, even though the 3 year total shareholder return is 49%. This suggests that longer term holders have still...

Rocket Pharmaceuticals (RCKT) is back in focus after the FDA granted accelerated approval for its gene therapy KRESLADI to treat pediatric patients with severe leukocyte adhesion deficiency I who lack matched sibling donors. See our latest analysis for Rocket Pharmaceuticals. Even with the FDA approval and accompanying priority review voucher, Rocket Pharmaceuticals’ recent share price performance has been weak, with a 1-month share price return of a 24.75% decline and a 1-year total...

National Fuel Gas (NYSE:NFG) entered into a new US$1.3b unsecured committed revolving credit facility with a group of major lenders. The new facility extends the company’s debt maturity profile to 2031 and amends prior credit agreements. Management plans to use the facility for repaying existing debt, general corporate purposes, and potential future investments. National Fuel Gas, a diversified energy company involved in natural gas exploration, production, gathering, and distribution, now...

Wondering whether FirstSun Capital Bancorp at around US$36.06 is giving you good value right now? This breakdown will help you judge the price with a clear set of valuation tools. The stock has returned 1.5% over the last 7 days, while the 30 day return is a 1.1% decline and the year to date move sits at a 4.6% decline, with a 4.5% decline over the past year and a 28.8% gain over 3 years. Recent coverage has focused on the bank's position within the wider US banking sector and how regional...

Director James S. Metcalf recently made a significant open market share purchase in Gibraltar Industries. This is his first open market buy since November 2024 and meaningfully increases his direct holdings. The transaction comes after a year of share price underperformance for NasdaqGS:ROCK. Gibraltar Industries, traded as NasdaqGS:ROCK, is drawing fresh attention after Director James S. Metcalf increased his direct ownership through a sizeable open market purchase. The move comes at a...

If you are wondering whether ASGN at a last close of US$37.56 is starting to look interesting on price alone, the valuation story behind that headline number is where things get more revealing. Over the past week the stock returned 4.1%, but that sits against a 12.4% decline over 30 days, a 19.5% decline year to date, and a 40.4% decline over 1 year that may have changed how investors view both risk and reward. Those returns sit within a longer slide, with 3 year and 5 year returns of 54.6%...

If you are wondering whether Hamilton Insurance Group's current share price still offers value after a strong run, the recent numbers give you plenty to think about. The stock closed at US$28.61, with a 0.2% move over the last 7 days, a 9.4% decline over 30 days, a 4.9% gain year to date, and a 43.5% return over the last year. These mixed short term moves against a strong 1 year return have put the focus squarely on what investors are now willing to pay for Hamilton Insurance Group and why...

Ollie's Bargain Outlet Holdings (NasdaqGM:OLLI) announced a planned merchandising leadership transition. Senior Vice President, General Merchandise Manager, Kevin McLain is set to retire effective May 1, 2026. Longtime merchandising executive Shane Thornton will assume the senior merchandising leadership role following McLain’s retirement. The move is part of the company’s succession planning for a function that sits at the core of Ollie’s closeout and treasure-hunt model. For investors...

If you are wondering whether Crane NXT is attractively priced or just a value trap, starting with a clear view of its recent share performance and fundamentals can help frame the question. The stock last closed at US$41.15, with a 1.9% gain over the past week, a 14.8% decline over the past month, a 13.8% decline year to date, and a 18.8% decline over the last year. Its 3 year return sits at 9.4%. Recent coverage has focused on providing evergreen context for Crane NXT, aiming to keep...

CECO and Thermon Group Holdings (NYSE:THR) announced a planned combination that management describes as a scale play with commercial synergies. The transaction is framed around Thermon's 3D strategy of decarbonization, digitalization, and diversification, as well as a shift toward more recurring revenue. Leadership highlights expectations for double-digit growth, improved EBITDA margins, and near term cross selling opportunities across the combined customer base. Thermon, known for...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...